AtriCure, Inc. (ATRC) is a publicly traded company in the Unknown sector. Across all available filings, 46 corporate insiders have executed 1020 transactions totaling $95.9M, demonstrating a bearish sentiment with -$87.3M in net insider flow. The most recent transaction on Dec 10, 2025 involved a transaction of 4,000 shares valued at $0.
No significant insider buying has been recorded for ATRC in the recent period.
No significant insider selling has been recorded for ATRC in the recent period.
Based on recent SEC filings, insider sentiment for ATRC is bearish with an Insider Alignment Score of 5/100 and a net flow of -$87.3M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at AtriCure, Inc. (ATRC) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 46 insiders are actively trading ATRC stock, having executed 1020 transactions in the past 90 days. The most active insider is Michael H. Carrel (Executive), who has made 125 transactions totaling $65.4M.
Get notified when executives and directors at ATRC file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Dec 10, 2025 | H. Carrel Michael | Executive | Gift | 4,000 | $N/A | $0 | |
| Nov 26, 2025 | J. Noznesky Justin | Executive | Sale | 5,166 | $37.29 | $192.6K | |
| Nov 25, 2025 | Wehrwein Sven | Executive | Sale | 4,967 | $38.00 | $188.7K | |
| Nov 25, 2025 | Wehrwein Sven | Executive | Option Exercise | 4,967 | $19.95 | $99.1K | |
| Nov 24, 2025 | Wehrwein Sven | Executive | Sale | 5,033 | $37.32 | $187.8K | |
| Nov 24, 2025 | Wehrwein Sven | Executive | Option Exercise | 5,033 | $19.95 | $100.4K | |
| Nov 21, 2025 | Yuen Maggie | Executive | Sale | 3,000 | $35.72 | $107.2K | |
| Nov 13, 2025 | H. Carrel Michael | Executive | Gift | 6,000 | $N/A | $0 | |
| Sep 12, 2025 | J. Noznesky Justin | Executive | Sale | 3,000 | $36.30 | $108.9K | |
| Aug 22, 2025 | Wehrwein Sven | Executive | Option Exercise | 5,000 | $19.95 | $99.8K | |
| Aug 22, 2025 | Wehrwein Sven | Executive | Sale | 5,000 | $37.00 | $185.0K | |
| Aug 19, 2025 | Wehrwein Sven | Executive | Option Exercise | 5,000 | $19.95 | $99.8K | |
| Aug 19, 2025 | Wehrwein Sven | Executive | Sale | 5,000 | $36.00 | $180.0K | |
| Aug 6, 2025 | E. Groves Regina | Executive | Sale | 2,452 | $36.82 | $90.3K | |
| Aug 5, 2025 | Doraiswamy Vinayak | Executive | Sale | 2,500 | $36.58 | $91.5K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 295 | $91.6M | 57.1% |
Payment(F) | 153 | $42.8M | 26.7% |
Exercise(M) | 136 | $20.7M | 12.9% |
Purchase(P) | 105 | $4.3M | 2.7% |
Award(A) | 284 | $1.1M | 0.7% |
Gift(G) | 30 | $0 | 0.0% |
Other(J) | 17 | $0 | 0.0% |
Insider selling pressure at AtriCure, Inc. has increased, with 46 insiders executing 1020 transactions across all time. Total sales of $91.6M significantly outpace purchases of $4.3M, resulting in a net outflow of $87.3M. This selling activity appears largely discretionary, which may warrant closer attention from investors.